Safety and Tolerability in Healthy Volunteers
9
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
A Study Testing the Effects of Different THC Doses on Psychological and Biological Function
Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers
Phase I Study of VLX-1005 in Healthy Subjects
A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)
Discrete(TM) Safety Clinical Trial GLAD-01
Single Dose Study of ANX005 in Healthy Volunteers
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects